Tulsi Pravin Roy, MD | |
2040 Ogden Ave Ste 115, Aurora, IL 60504-7205 | |
(630) 922-8825 | |
Not Available |
Full Name | Tulsi Pravin Roy |
---|---|
Gender | Female |
Speciality | Plastic And Reconstructive Surgery |
Experience | 9 Years |
Location | 2040 Ogden Ave Ste 115, Aurora, Illinois |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063892354 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Rush University Medical Center | Chicago, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rush University Medical Center | 5496658874 | 1007 |
Rush-copley Medical Group Nfp | 7618864877 | 108 |
News Archive
A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming.
BD Diagnostics, a segment of BD, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS Assay for Group B Streptococcus on the BD MAX System. The BD MAX System is a next-generation automated workstation for molecular testing designed to streamline workflow and offer full walkaway automation to accommodate varying workloads for maximum lab efficiency and flexibility.
The Wall Street Journal: "The Justice Department is trying to take the lead in a lawsuit accusing Pfizer Inc.'s Wyeth unit of improperly promoting an organ-transplant drug for unauthorized uses and paying illegal kickbacks to doctors. The lawsuit was filed by two former Wyeth sales representatives who were responsible for promoting Rapamune, an immunosuppressant used to prevent the body's rejection of transplanted kidneys.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that current and former users of marijuana are more likely to have prediabetes-the state of poor blood sugar control that can progress to type 2 diabetes-than never users of marijuana. However the researchers, led by Mike Bancks (University of Minnesota School of Public Health, Minneapolis, MN, USA) failed to establish a direct link between marijuana use and type 2 diabetes.
In the March 1 issue, Drs. Johanna Joyce (MSKCC), Douglas Hanahan (UCSF) and colleagues lend new insight into how broad-spectrum cysteine cathepsin inhibitors combat pancreatic cancer, and provide new data to help refine the design of more precisely targeted anti-cathepsin therapies.
› Verified 1 days ago
Entity Name | Rush University Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093819542 PECOS PAC ID: 5496658874 Enrollment ID: O20040202000228 |
News Archive
A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming.
BD Diagnostics, a segment of BD, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS Assay for Group B Streptococcus on the BD MAX System. The BD MAX System is a next-generation automated workstation for molecular testing designed to streamline workflow and offer full walkaway automation to accommodate varying workloads for maximum lab efficiency and flexibility.
The Wall Street Journal: "The Justice Department is trying to take the lead in a lawsuit accusing Pfizer Inc.'s Wyeth unit of improperly promoting an organ-transplant drug for unauthorized uses and paying illegal kickbacks to doctors. The lawsuit was filed by two former Wyeth sales representatives who were responsible for promoting Rapamune, an immunosuppressant used to prevent the body's rejection of transplanted kidneys.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that current and former users of marijuana are more likely to have prediabetes-the state of poor blood sugar control that can progress to type 2 diabetes-than never users of marijuana. However the researchers, led by Mike Bancks (University of Minnesota School of Public Health, Minneapolis, MN, USA) failed to establish a direct link between marijuana use and type 2 diabetes.
In the March 1 issue, Drs. Johanna Joyce (MSKCC), Douglas Hanahan (UCSF) and colleagues lend new insight into how broad-spectrum cysteine cathepsin inhibitors combat pancreatic cancer, and provide new data to help refine the design of more precisely targeted anti-cathepsin therapies.
› Verified 1 days ago
Entity Name | Rush-copley Medical Group Nfp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093075848 PECOS PAC ID: 7618864877 Enrollment ID: O20040310001029 |
News Archive
A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming.
BD Diagnostics, a segment of BD, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS Assay for Group B Streptococcus on the BD MAX System. The BD MAX System is a next-generation automated workstation for molecular testing designed to streamline workflow and offer full walkaway automation to accommodate varying workloads for maximum lab efficiency and flexibility.
The Wall Street Journal: "The Justice Department is trying to take the lead in a lawsuit accusing Pfizer Inc.'s Wyeth unit of improperly promoting an organ-transplant drug for unauthorized uses and paying illegal kickbacks to doctors. The lawsuit was filed by two former Wyeth sales representatives who were responsible for promoting Rapamune, an immunosuppressant used to prevent the body's rejection of transplanted kidneys.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that current and former users of marijuana are more likely to have prediabetes-the state of poor blood sugar control that can progress to type 2 diabetes-than never users of marijuana. However the researchers, led by Mike Bancks (University of Minnesota School of Public Health, Minneapolis, MN, USA) failed to establish a direct link between marijuana use and type 2 diabetes.
In the March 1 issue, Drs. Johanna Joyce (MSKCC), Douglas Hanahan (UCSF) and colleagues lend new insight into how broad-spectrum cysteine cathepsin inhibitors combat pancreatic cancer, and provide new data to help refine the design of more precisely targeted anti-cathepsin therapies.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Tulsi Pravin Roy, MD 5841 S Maryland Ave # Mc6035, Suite J-641, Chicago, IL 60637-1447 Ph: (773) 702-6302 | Tulsi Pravin Roy, MD 2040 Ogden Ave Ste 115, Aurora, IL 60504-7205 Ph: (630) 922-8825 |
News Archive
A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming.
BD Diagnostics, a segment of BD, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS Assay for Group B Streptococcus on the BD MAX System. The BD MAX System is a next-generation automated workstation for molecular testing designed to streamline workflow and offer full walkaway automation to accommodate varying workloads for maximum lab efficiency and flexibility.
The Wall Street Journal: "The Justice Department is trying to take the lead in a lawsuit accusing Pfizer Inc.'s Wyeth unit of improperly promoting an organ-transplant drug for unauthorized uses and paying illegal kickbacks to doctors. The lawsuit was filed by two former Wyeth sales representatives who were responsible for promoting Rapamune, an immunosuppressant used to prevent the body's rejection of transplanted kidneys.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that current and former users of marijuana are more likely to have prediabetes-the state of poor blood sugar control that can progress to type 2 diabetes-than never users of marijuana. However the researchers, led by Mike Bancks (University of Minnesota School of Public Health, Minneapolis, MN, USA) failed to establish a direct link between marijuana use and type 2 diabetes.
In the March 1 issue, Drs. Johanna Joyce (MSKCC), Douglas Hanahan (UCSF) and colleagues lend new insight into how broad-spectrum cysteine cathepsin inhibitors combat pancreatic cancer, and provide new data to help refine the design of more precisely targeted anti-cathepsin therapies.
› Verified 1 days ago